Literature DB >> 26203931

A method for evaluation of proton plan robustness towards inter-fractional motion applied to pelvic lymph node irradiation.

Andreas G Andersen1, Oscar Casares-Magaz1, Ludvig P Muren1, Jakob Toftegaard1, Lise Bentzen2, Sara Thörnqvist3, Jørgen B B Petersen1.   

Abstract

BACKGROUND: The benefit of proton therapy may be jeopardized by dose deterioration caused by water equivalent path length (WEPL) variations. In this study we introduced a method to evaluate robustness of proton therapy with respect to inter-fractional motion and applied it to irradiation of the pelvic lymph nodes (LNs) from different beam angles. Patient- versus population-specific patterns in dose deterioration were explored.
MATERIAL AND METHODS: Patient data sets consisting of a planning computed tomography (pCT) as well as multiple repeat CT (rCT) scans for three patients were used, with target volumes and organs at risk (ORs) outlined in all scans. Single beam spot scanning proton plans were optimized for the left and right LN targets separately, across all possible beam angle configurations (5° angle intervals). Isotropic margins of 0, 3, 5 and 7 mm from the clinical target volume (CTV) to the planning target volume (PTV) were investigated. The optimized fluence maps for the pCT for each beam were applied onto all rCTs and the dose distributions were re-calculated. WEPL variation for each beam angle was computed by averaging over beams eye view WEPL distributions.
RESULTS: Similarity in deterioration patterns were found for the investigated patients, with beam angles delivering less dose to rectum, bladder and overall normal tissue identified around 40° and around 150°-160° for the left LNs, and corresponding angles for the right LNs. These angles were also associated with low values of WEPL variation.
CONCLUSION: We have established and explored a method to quantify the robustness towards inter-fractional motion of single beam proton plans treating the pelvic LNs from different beam configurations and with different CTV to PTV margins. For the patients investigated we were able to identify beam orientations that were robust to dose deterioration in the target and ORs.

Entities:  

Mesh:

Year:  2015        PMID: 26203931     DOI: 10.3109/0284186X.2015.1067720

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  4 in total

1.  On-line dose-guidance to account for inter-fractional motion during proton therapy.

Authors:  Kia Busch; Ludvig P Muren; Sara Thörnqvist; Andreas G Andersen; Jesper Pedersen; Lei Dong; Jørgen B B Petersen
Journal:  Phys Imaging Radiat Oncol       Date:  2018-12-19

2.  Evaluation of an a priori scatter correction algorithm for cone-beam computed tomography based range and dose calculations in proton therapy.

Authors:  Andreas Gravgaard Andersen; Yang-Kyun Park; Ulrik Vindelev Elstrøm; Jørgen Breede Baltzer Petersen; Gregory C Sharp; Brian Winey; Lei Dong; Ludvig Paul Muren
Journal:  Phys Imaging Radiat Oncol       Date:  2020-10-27

3.  A biological modelling based comparison of radiotherapy plan robustness using photons vs protons for focal prostate boosting.

Authors:  Jesper Pedersen; Oscar Casares-Magaz; Jørgen B B Petersen; Jarle Rørvik; Lise Bentzen; Andreas G Andersen; Ludvig P Muren
Journal:  Phys Imaging Radiat Oncol       Date:  2018-07-18

4.  Dosimetric Uncertainties in Dominant Intraprostatic Lesion Simultaneous Boost Using Intensity Modulated Proton Therapy.

Authors:  Jun Zhou; Xiaofeng Yang; Chih-Wei Chang; Sibo Tian; Tonghe Wang; Liyong Lin; Yinan Wang; James Robert Janopaul-Naylor; Pretesh Patel; John D Demoor; Duncan Bohannon; Alex Stanforth; Bree Eaton; Mark W McDonald; Tian Liu; Sagar Anil Patel
Journal:  Adv Radiat Oncol       Date:  2021-10-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.